2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with quinazolines in 1 studies
| Studies (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Trials (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Recent Studies (post-2010) (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 85 | 0 | 62 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | 2-(4-morpholinoanilino)-6-cyclohexylaminopurine (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Jiang, CC; Yu, W; Zheng, JG | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and quinazolines
| Article | Year |
|---|---|
Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study.
Topics: Antineoplastic Agents; Binding Sites; Cell Cycle Proteins; Drug Design; Drug Resistance, Neoplasm; Humans; Molecular Dynamics Simulation; Morpholines; Mutation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Purines; Pyrazoles; Quinazolines | 2018 |